During the recent Charing Cross (CX) International Symposium held in London, Robert Shahverdyan, MD detailed the challenges associated with the use of current endovascular arteriovenous fistula (endoAVF) devices and provided insights from his clinical experience with Venova Medical’s Velocity System during initial cases performed for the VENOS-1 early feasiblity study (NCT05757726). He communicated that the Velocity System is a new endoAVF device that enables an end-to-side connection from the proximal radial artery to the perforator vein “without losing any flow into the deep venous system”.
CLICK HERE to read a more detailed review of Dr. Shahverdyan’s presentation which appears in Renal Interventions.
